Beth Hecht

CIK 1652410 · See Remarks · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.01M

Companies

4

Total Filings

42

Lifetime Open-Market Net

-$1.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XERS See Remarks 1,176,506 $6.79 $7.99M -$1.06M 27 2026-06-02
Iterum Therapeutics plc (ITRM) Delisted Director 18,839 $0.03 $565 $0 6 2023-06-15
AYTU Director 9,052 $2.15 $19.5K $0 1 2021-04-12
Neos Therapeutics, Inc. (NEOS) Delisted Director 0 $1.15 $0 $0 7 2021-03-19

Recent Filings · Page 3 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-10-05 Grant (A) +206,366 $0
2021-06-25 Iterum Therapeutics plc (ITRM) Delisted Grant (A) $0 EDGAR
2021-04-12 AYTU Grant (A) +6,500 $0 EDGAR
2021-03-19 Neos Therapeutics, Inc. (NEOS) Delisted Disp (D) −23,453 $0 EDGAR
2021-03-19 Iterum Therapeutics plc (ITRM) Delisted Grant (A) $0 EDGAR
2021-02-01 XERS Grant (A) +150,000 $0 EDGAR
2020-08-17 XERS Grant (A) $0 EDGAR
2020-07-15 XERS Grant (A) +3,731 $8.4K EDGAR
2020-06-11 Neos Therapeutics, Inc. (NEOS) Delisted Grant (A) +23,453 $0 EDGAR
2020-03-16 XERS Buy (P) +4,000 $7.9K EDGAR
Showing 2130 of 42
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.